European Pharmaceutical Review

JANUARY 2, 2024

highlighted that “in the EU market, a relatively low number of approved pharmaceutical products adopted the QbD methodology or describe QbD elements in their regulatory submissions.” For example, Simões et al. The team examined the European Public Assessment Report (EPAR) for the QbD approach.

Pharmaceutical products 95

Pharmaceutical products Pharmaceutical Manufacturing Marketing 95

European Pharmaceutical Review

SEPTEMBER 6, 2023

percent from 2023 to 2028. Between 2023 to 2028, the research suggested that a greater focus on drug development, growing requirement for spectroscopy via cloud-based platforms, alongside the industry’s need for precise and effective analytical methods, will drive the market. million by 2028, with a CAGR of 7.3

Marketing 82

Marketing Distribution Pharmaceutical products Media 82

World of DTC Marketing

MARCH 10, 2022

market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. billion last year, the highest total for any pharmaceutical product and they will do anything to keep that money. Sales of Humira earned AbbVie $20.7 The executives at AbbVie make over $300 million.

Prescription 205

Prescription Pharmaceutical products Pharmaceutical Manufacturing 205

European Pharmaceutical Review

OCTOBER 24, 2023

percent between the forecast period: 2023 and 2028. Packaging materials As an “integral part of the pharmaceutical product”, the report authors stated that within the packaging segment in this market, in 2022, the primary packaging segment held the highest share of 70.40 percent between the forecast period 2023-2028.

Pharmaceutical 98

Pharmaceutical Marketing Medicine Pharmaceutical Sales 98

Pharmaceutical Technology

JUNE 12, 2023

Teraju Pharma will be responsible for marketing and promoting the products using its relationships and infrastructure. The company is a specialised pharmaceutical wholesaler and holds a licence, issued by the country’s ministry of health, to import non-registered pharmaceutical products, orphan drugs and other life-saving medicines.

Pharmaceutical 97

Pharmaceutical Marketing Pharma Pharmaceutical products 97

European Pharmaceutical Review

MARCH 27, 2024

percent from 2023 to 2032, according to the research. Drivers of the pyrogen testing market Increased R&D activities within the pharmaceutical and biopharmaceutical sector and a focus on biologics, were reported to hold significant growth opportunities for the pyrogen testing market. billion by 2032.

Safety 69

Safety Marketing Food and Drug Administration Pharmaceutical 69

European Pharmaceutical Review

APRIL 17, 2023

percent during the forecast period 2023-2033. million in 2023, according to the data. Factors impacting the automation in the biopharma industry market The report found that 75 percent of pharmaceutical organisations want to use automated solutions more frequently. The market’s overall world revenue value will exceed $1,855.0

Biopharma 90

Biopharma Manufacturing Pharmaceutical products Marketing 90

European Pharmaceutical Review

MARCH 11, 2024

Additionally, this can be caused by “poor handling, repackaging, and nonadherence to good manufacturing practices [GMP] during dispensing and packaging have resulted in the microbiological contamination of non-sterile pharmaceutical products.” Ahmed et al. One case of drug contamination from 2021 was highlighted in the paper.

Pharmaceutical 83

Pharmaceutical Food and Drug Administration Manufacturing Pharmaceutical products 83

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. market (source: IQVIA MIDAS, May 2023). billion people in 2023). in the top five European Union markets and 7.1%

Marketing 105

Marketing Insurance Medical Manufacturing 105

European Pharmaceutical Review

JANUARY 9, 2024

Through exploration of various applications, crises and case studies, the paper takes a look at how AI is promising to take pharmaceuticals forward toward ever-higher standards for quality control, compliance and operational efficiency. 2023; 44(3):1384-1392. Figure 1 : adapted from Saha, G. ” References Saha GC.

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

European Pharmaceutical Review

JANUARY 26, 2023

These concentration measurements are used as part of regulatory decisions regarding the safety and efficacy of medicinal products. Implementation of the ICH M10 document The EU date of coming into effect of the core ICH M10 document and the corresponding Q&As was 21 January 2023.

Food and Drug Administration 88

Food and Drug Administration Medicine Pharmaceutical products Pharmaceutical 88

European Pharmaceutical Review

APRIL 19, 2023

percent from 2023, according to the data. Smart packaging has potential for the integration of electronic functionality, enabling compliance, material identification, condition monitoring and asset tracking of pharmaceutical products. This represents a compound annual growth rate (CAGR) of 15.4

Electronics 75

Electronics Marketing Pharmaceutical products Pharmaceutical 75

European Pharmaceutical Review

NOVEMBER 3, 2022

Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Industry challenges for the year ahead.

Pharma 80

Pharma Manufacturing Competition Pharmaceutical products 80

European Pharmaceutical Review

JUNE 30, 2023

Between 2023 and 2032, this market is estimated to have an compound annual growth rate (CAGR) of 13.8 A limitation to implementing PAT in pharmaceutical production is that infrastructure such as hardware and software is expensive. Growth and limitations in the global PAT market The PAT market is expected to grow $10.6

Marketing 90

Marketing Manufacturing Pharmaceutical Pharmaceutical products 90

European Pharmaceutical Review

JANUARY 12, 2024

Prior to joining Clarivate, Levy held several roles in the pharmaceutical industry, including at Veeva Systems, Pharmaceutical Product Development (PPD) and Accenture. Use of artificial intelligence (AI) and machine learning (ML) in pharma “AI/ML is in most technologies, and in most pharmaceutical companies,” Levy explains.

Pharma 78

Pharma Pharmaceutical Recruitment Pharmaceutical products 78

European Pharmaceutical Review

JULY 21, 2023

Europe, too, has faced similar issues with its pharmaceutical supply chain, including critical shortages of antibiotics such as amoxicillin. Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. How can these issues be addressed?

Pharmaceutical 94

Pharmaceutical Food and Drug Administration Transportation Manufacturing 94

European Pharmaceutical Review

DECEMBER 19, 2023

TRS 953 – Annex 2, Appendix 1: Stability testing of active pharmaceutical ingredients and finished pharmaceutical products: Stability conditions for WHO Member States by Region. Since vaccines can now be reformulated to meet the relevant WHO guidelines, the route to a future of fridge-free vaccines is open. Internet] WHO.

Distribution 99

Distribution Manufacturing Food Specialization 99

Clarivate

MARCH 14, 2024

5] Regulatory developments and their impact In January of 2023, Denmark, Germany, the Netherlands, Sweden, and Norway proposed an EU-wide ban on a large cache of per- and polyfluoroalkyl substances (PFAS) under Registration, Evaluation, Authorization and Restriction of Chemicals (REACH).

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

European Pharmaceutical Review

APRIL 21, 2023

4 Together with a legal expert from the Bucerius Law School Hamburg, we looked at the legal and political frameworks that could enable the German pharmaceutical sector to become more sustainable. Strengthening sustainability in the pharmaceutical sector. Dessau-Roßlau: German Environment Agency. Baltruks D, Sowa M, Voss M.

Pharma 81

Pharma Food and Drug Administration Medicine Pharmaceutical 81

Pharmaceutical Technology

MARCH 22, 2023

In the US Drug Quality and Security Act (DSCSA), the FDA mandates that manufacturers and trading partners should have full interoperable electronic track and trace systems in place by November 2023. RFID is an important facet of smart labelling and its evolution, but not the only one.

Food and Drug Administration 105

Food and Drug Administration Electronics Pharma FDA 105

PharmaKinnex

SEPTEMBER 2, 2022

Before you sit down for your Q4 planning session (we’ll cover that in our next blog), have you and your team stopped to consider what you could do to improve product life cycles in 2023?

Sales 52

Sales Marketing Pharmaceutical Pharmaceutical Sales 52

European Pharmaceutical Review

DECEMBER 27, 2023

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. Approved cellular and gene therapy products [Internet]. FDA; 2022 [cited 2023 Mar]. 2021;3(S1):6–10. Center for Biologics Evaluation and Research.

Manufacturing 83

Manufacturing Food and Drug Administration Patients Pharma 83

Pharmaceutical Technology

JANUARY 16, 2023

Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. To some extent, the pharmaceutical sector is more resilient to these challenges than other industries. Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023.

Pharma 64

Pharma Manufacturing Pharmaceutical Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. To some extent, the pharmaceutical sector is more resilient to these challenges than other industries. Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023.

Pharma 52

Pharma Manufacturing Pharmaceutical Marketing 52

Pharmaceutical Technology

JUNE 8, 2023

Pfizer, in addition to promising carbon neutrality by the same date via a 46% reduction in direct emissions and 100% renewable electricity purchasing, says its North American operations will be entirely solar powered by the end of 2023. The pharmaceutical industry is reshaping itself in a more environmentally and socially conscious image.

Pharmaceutical 52

Pharmaceutical Media Transportation Pharma 52

Pharmaceutical Technology

MARCH 30, 2023

As an independent contract testing laboratory, Butterworth has extensive experience testing a wide range of excipients and APIs to Pharmacopoeial monographs and other validated methods, for our clients which are used in the manufacture of a broad range of pharmaceutical products sold around the world.

Manufacturing 52

Manufacturing Medicine Pharmaceutical Pharmaceutical manufacturing 52